Side-by-side comparison
Pentadeca Arginate (PDA) vs Anamorelin
Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair. versus Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Pentadeca Arginate (PDA)
RecoveryArginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Top benefits
- ✓Tendon and ligament healing
- ✓Better stability than BPC-157 acetate
- ✓Anti-inflammatory
Anamorelin
PerformanceOral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Top benefits
- ✓Increases lean body mass
- ✓Improves appetite
- ✓Oral bioavailability
| Attribute | Pentadeca Arginate (PDA) | Anamorelin |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | small-molecule |
| Chain length | 15 aa | 1 aa |
| Formula | BPC-157 arginate salt | C31H42N6O3 |
| Common dose | 250-500 mcg | 100 mg |
| Frequency | 1-2x daily SC | Daily, oral |
| Top benefit | Tendon and ligament healing | Increases lean body mass |
| Top side-effect | Injection-site irritation | Hyperglycemia |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.